MGNX · Macrogenics Inc
$4.22
+0.14 (+3.43%)
At close · Aug 14
Market Cap
$268.81M
Shares
63.70M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2024-04-04 | Peters Jeffrey Stuart | Officer | 51,395 | 2024-04-04 | Merrill Lynch |
| 2024-03-06 | Peters Jeffrey Stuart | Officer | 19,625 | 2024-03-06 | Merrill Lynch |
| 2024-03-04 | Karrels James | Officer | 30,000 | 2024-03-04 | Oppenheimer & Co Inc |
| 2024-03-04 | Risser Eric Blasius | Officer | 41,159 | 2024-03-04 | Merrill Lynch |
| 2024-03-04 | Spitznagel Thomas | Officer | 10,000 | 2024-03-04 | Merrill Lynch |
| 2024-02-26 | Peters Jeffrey Stuart | Officer | 16,124 | 2024-02-26 | Merrill Lynch |
| 2024-02-07 | Bonvini Ezio | Officer | 3,334 | 2024-02-07 | Merrill Lynch |
| 2024-02-05 | Peters Jeffrey Stuart | Officer | 76,251 | 2024-02-05 | Merrill Lynch |
| 2024-02-01 | Bonvini Ezio | Officer | 13,316 | 2024-02-01 | Merrill Lynch |
| 2024-01-19 | Bonvini Ezio | Officer | 13,316 | 2024-01-19 | Merrill Lynch |
| 2023-12-20 | Bonvini Ezio | Officer | 18,880 | 2023-12-20 | Merrill Lynch |
Showing 1–11 of 11 filings
Key facts
CIK
1125345
CUSIP
556099109
13F (30d)
126 filings
122 filers
Visit website
Investor relations